Pharma Press Releases
Keep up to date with the latest technological developments happening across the Pharmaceutical industry. Our press releases can help you boost your online reach and exposure worldwide. Our Press releases provides information on the latest research in pharma.
Merck’s Letermovir, an Investigational Antiviral Medicine for Prevention of Cytomegalovirus (CMV) Infection in Bone Marrow Transplant Recipients, Highly Effective Through Week 24 Post-Transpl
Monday, February 27, 2017Merck Co Inc known as MSD outside the United States and Canada today announced results of the pivotal Phase clinical study of letermovir an investigational antiviral medicine for the prevention of clinicallysignificant cytomegalovirus CMV infection...
Antibe Therapeutics Enters into Regional Licensing Deal
Saturday, February 25, 2017Antibe Therapeutics Inc is pleased to announce today that it has signed an exclusive licensing and distribution agreement with Laboratories Acbel SA Acbel for ATB in Greece Romania Serbia Bulgaria Albania Algeria and Jordan Acbel is a pharmaceutical...
Acticor Biotech Has Selected Its Contract Research Organisation to Manage Clinical Study Phase I
Friday, February 24, 2017Acticor Biotech a biotechnology company focused on the treatment of acute ischemic stroke today announced that it selected its CRO Contract Research Organization to manage its clinical study phase I The firstinhuman study with ACT will be conducte...
Fusion Pharmaceuticals Launches with a $25M USD Series A Financing to Develop Targeted Radiotherapeutics as Cancer Treatments
Friday, February 24, 2017Fusion Pharmaceuticals a newly formed biopharmaceutical company developing targeted alphaparticle radiotherapeutics for treating cancer today announced the closing of a million Series A financing led by founding venture investor Johnson Johnson Inn...
Lannett Provides Further Update On Methylphenidate ER Tablets
Thursday, February 23, 2017Lannett Company Inc announced that it was notified by US Food and Drug Administration FDA late yesterday afternoon that FDA suspended indefinitely the deadline for the Company to submit materials in support of its request for a hearing to consider FD...
PMV Pharma Secures $74 Million in Series B Financing for Cancer Drugs Targeting p53
Thursday, February 23, 2017PMV Pharmaceuticals Inc a leader in the discovery and development of ptargeted small molecule drugs for the treatment of cancer today announced the completion of a million Series B financing round This financing was led by Topspin Biotech Fund and a...
CohBar, Inc. Announces Positive Results from Preclinical NASH Study of its Lead Drug Candidates
Wednesday, February 22, 2017CohBar Inc a preclinical stage biotechnology company focused on developing mitochondria based therapeutics MBTs to treat agerelated diseases announced today that it has completed a study to evaluate the potential efficacy of its lead drug candidates...
Eagle Pharmaceuticals Announces New Patents Issued for Bendeka
Wednesday, February 22, 2017Eagle Pharmaceuticals Inc announced that four additional patents have been issued related to Bendeka by the United States Patent and Trademark Office USPTO Patent numbers and will expire January Patent numbers and will expire March The US Paten...
Lysogene Receives Orphan Drug Designation from EMA for LYS-GM101 for Treatment of GM1 Gangliosidosis
Wednesday, February 22, 2017Lysogene a leading clinicalstage biotechnology company specializing in gene therapy for rare central nervous system diseases today announces that the European Medicines Agency EMA has granted orphan drug designation to LYSGM the Companys gene therapy...
Envigo’s fully validated highly sensitive method enables completion of thyroid hormone tests in accordance with OECD guidelines Liquid chromatography-mass spectrometry technique can detect T
Wednesday, February 22, 2017Envigo is pleased to announce that it has developed and validated a robust analytical method to evaluate the potential effects on thyroid hormone levels in rat F offspring It is now possible for Envigo to successfully determine levels of T triiodothy...
